Court orders NuVasive to pay $60M in damages over trademark use

10/28/2010 | Reuters

A U.S. district court ordered NuVasive to pay Neurovision Medical Products $60 million in damages in a case over NuVasive's use of the NeuroVision trademark for a spinal-surgical product. NuVasive said it plans to appeal the ruling, and that the damages amount could change.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY